Anti-nuclear Antibody (ANA) Testing new booming trends in 2023
The Global Anti-nuclear Antibody (ANA) Testing Market is
growing with the rapid pace; mainly due the burgeoning Healthcare Sector.
According to a recent study report published by the Market Research Future, The
global Anti-nuclear Antibody (ANA) Testing Market is
booming and expected to gain prominence over the forecast period.
Global Anti-nuclear
Antibody (ANA) Testing Market information, by type (immunofluorescence,
enzymelinked, immunosorbent assay (ELISA) and others), by application
(Rheumatoid arthritis, Systemic lupus erythematosus (SLE), Polymyositis,
Scleroderma, Sjögren's syndrome, and others), by End User (Hospitals and
clinics, research laboratories, and others) - Forecast to 2023
Anti-nuclear Antibody (ANA) Test is used to detect
antinuclear antibodies in blood. Immune system makes antibodies to fight with
various infections. Antinuclear antibodies often attack on own tissues. ANA
test helps to determine autoimmune diseases like rheumatoid arthritis and
lupus. Increasing technological advancements, adoption of new techniques and
increasing prevalence of various autoimmune diseases are driving the growth for
global anti-nuclear antibody (ANA) testing market. Major brands are investing
money in R&D to develop more advanced product for the market that is
another key driver for the market.
The Global Anti-nuclear Antibody (ANA) testing
market is growing at the CAGR of ~9.6% during the forecast period and expected
to reach US$ 1300.6 million by 2023.
Key Players for Global Anti-nuclear Antibody (ANA)
Testing Market:
Some of the key players in this market are: Abcam
plc. (US), Alere (US), Antibodies Inc.(US), Bio-Rad Laboratories, Inc. (US),
Erba Diagnostics (US), Indur Services, Inc. (US), MBL INTERNATIONAL (US), Merck
KGaA (Germany), Trinity Biotech (Republic of Ireland)
Segments:
Global Anti-nuclear Antibody (ANA) Testing Market
has been segmented on the basis of type which comprise immunofluorescence (Primary
or direct and Secondary or indirect), enzymelinked, immunosorbent assay (ELISA)
(Direct ELISA, Indirect ELISA, Sandwich ELISA, Competition/Inhibition ELISA),
and others. On the basis of application, it segmented into Rheumatoid arthritis
(Seropositive, Seronegative), Systemic lupus erythematosus (SLE) (Discoid lupus
erythematosus, Subacute cutaneous lupus erythematosus, Neonatal lupus),
Polymyositis, Scleroderma (localized scleroderma, systemic scleroderma),
Sjögren's syndrome (Primary, secondary) , and others. On the basis of end user,
it segmented into Hospitals and clinics, research laboratories, and others.
Regional Analysis of Global Anti-nuclear Antibody
(ANA) Testing Market:
Considering the global scenario of the market,
North America is largest market for Anti-nuclear Antibody (ANA) Testing, in
North America region US hold largest market share while European market is
second largest, and especially the growth rate is higher in west European
countries. On the other hand, Asia-Pacific (APAC) is fastest growing market and
expected to grow significantly during the forecast period. Middle East and
Africa (ME&A) is likely to have a limited growth in the market due to less
awareness of devices and treatment.
The report for Global Anti-nuclear Antibody (ANA)
Testing Market of Market Research Future comprises extensive primary research
along with the detailed analysis of qualitative as well as quantitative aspects
by various industry experts, key opinion leaders to gain the deeper insight of
the market and industry performance. The report gives the clear picture of
current market scenario which includes historical and projected market size in
terms of value and volume, technological advancement, macro economical and
governing factors in the market. The report provides details information and
strategies of the top key players in the industry. The report also gives a
broad study of the different markets segments and regions
Study objectives of Global
Anti-nuclear Antibody (ANA) Testing Market:
To provide detailed analysis of the
Global Anti-nuclear Antibody (ANA) Testing market structure with historical and
forecast revenue for the next 7 years of the various segments and sub-segments
of the Anti-nuclear Antibody (ANA) Testing Market
To provide insights about the key
drivers, restraints, opportunities and challenges that affecting the growth of
the Anti-nuclear Antibody (ANA) Testing market
To provide analysis of the market
with respect to four main geographies and their countries- Americas, Europe,
Asia-Pacific, and Middle East & Africa.
To provide detail analysis of the
market that segmented on the basis of type, by application, by end user, and
its sub-segments.
To provide detail analysis of global
Anti-nuclear Antibody (ANA) testing market mainly based on value chain
analysis, Porter’s five forces, Price analysis, and Supply Chain analysis etc.
To provide detail country level
analysis of the market with respect to the current market size and future
prospective
To track and analyze competitive
developments such as joint ventures, strategic alliances, mergers and
acquisitions, new product developments, and research and developments in the
Global Anti-nuclear Antibody (ANA) Testing Market
To provide overview of key players
and their strategic profiling in the market, comprehensively analyzing their
core competencies, and drawing a competitive landscape for the Anti-nuclear
Antibody (ANA) Testing market
Table of Content
1.
Report Prologue
2.
Introduction
3.
Research Methodology
4.
Market Dynamics
5.
Market Factor Analysis
6.
Global Anti-Nuclear Antibody (ANA) Testing
Market By Type
7.
Global Anti-Nuclear Antibody (ANA) Testing Market
By Application
8.
Global Anti-Nuclear Antibody (ANA) Testing Market By End User
9.
Global Anti-Nuclear Antibody (ANA) Testing Market By Region
10. Competitive
Landscape
11. Company Profile
12. Conclusion
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand,
Market
Research Future
+1
646 845 9312
Email:
sales@marketresearchfuture.com
Comments
Post a Comment